Del. Action Against CytRx Stayed Pending Calif. Court Deals
A Delaware Chancery Court judge has stayed a derivative action accusing biopharmaceutical company CytRx Corp.'s board of sanctioning a brazen stock-pumping scheme, finding the suing investors filed their case late and...To view the full article, register now.
Already a subscriber? Click here to view full article